The Changing Role of Analytical Science in Drug Discovery
By James Strachan
August 27, 2026
How complex biological models, larger datasets, and laboratory automation are shaping drug discovery decisions
3 min read
False
Pharma & Biopharma
Single-Cell Analysis Reveals Hidden CAR T Manufacturing Risks
August 10, 2026
Mission Bio’s Mike Molnar explains how single-cell multiomics could improve vector copy number analysis, product characterization, and safety assessment in CAR T development
5 min read
Can Immunopeptidomics Redefine Cancer Immunotherapy Development?
By Katherine Tran
August 3, 2026
Immunopeptidomics is helping researchers identify tumor-presented antigens that could inform the development of targeted cell therapies and personalized cancer vaccines
3 min read
Scaling Genomics for Precision Medicine
July 27, 2026
How advances in microarray technology are helping bring genomic data closer to real-time clinical decision-making
4 min read
The Secrets of the Gut
By Christina Casén
July 20, 2026
Going beyond the gut: why microbiome testing is the next big thing in drug development
3 min read
News and Research
News & Research
Mass Spectrometry
Data & AI
Technology
Pharma & Biopharma
Innovation
Business-in-Brief: June 2026
July 2, 2026
This month’s analytical science business news: Merck’s Bio-Techne acquisition, plus major ASMS product launches
3 min read
The New Reality of Peptide Analysis
June 15, 2026
Kelly Broster of Thermo Fisher Scientific explains why GLP-1 peptides are exposing the limits of traditional analytical workflows
6 min read
Precision Diagnostics and the ADC Revolution
June 10, 2026
Antibody-drug conjugates are transforming cancer care, but their success depends on more precise, sensitive, and data-driven diagnostics
13 min read
Taming “The Monster” – with Koen Sandra
June 9, 2026
Ahead of ISC2026 in Prague, Koen Sandra explores how analytical scientists are rising to the challenge posed by increasingly intimidating biotherapeutics
11 min read
Vaccine Analysis for a New Era
June 8, 2026
As vaccine technologies continue to expand, David Hage explores how analytical methods must evolve to meet growing demands for safety, quality, and activity testing
9 min read
